| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 82621 |
DSPE-PEG45-NHCO-CH2CH2COOH 磷脂-四十五聚乙二醇-NHCO-丙酸 |
186 |
zyl |
2024-12-24 |
| 82622 |
HO-PEG12-CH2CH2COOH |
177 |
h |
2024-12-24 |
| 82623 |
Hydroxy-PEG12-acid具体解释和潜在应用 |
150 |
h |
2024-12-24 |
| 82624 |
mPEG45-OCH2CH2COONHS Ester的结构式 |
190 |
zyl |
2024-12-24 |
| 82625 |
镍卟啉配合物,Ni(bpy)(t−BuOPTPP) |
203 |
WYQ |
2024-12-24 |
| 82626 |
Cbz-N-Amido-PEG8-CH2COOH,1334177-87-5 |
196 |
wyh |
2024-12-24 |
| 82627 |
Fmoc-Phe -Lys(Trt)-PAB-PNP,1116086-09-9,ADC试剂 |
148 |
hyy |
2024-12-24 |
| 82628 |
H2N-PEG45-DSPE H2N-聚乙二醇45-磷脂 |
246 |
zyl |
2024-12-24 |
| 82629 |
HO-PEG10-CH2CH2COOH |
150 |
h |
2024-12-24 |
| 82630 |
HS-PEG5-CH2CH2COOH |
149 |
h |
2024-12-24 |
| 82631 |
阿加曲班脂质体,Argatroban Liposome |
270 |
axc |
2024-12-24 |
| 82632 |
5-(2-庚氧基苯基)-10,15,20-三对氯苯基卟啉 ,H2 T(2−OH)PP |
150 |
WYQ |
2024-12-24 |
| 82633 |
Hydroxy-PEG3-t-butyl acetate,羟基三聚乙二醇乙酸叔丁酯 |
185 |
wyh |
2024-12-24 |
| 82634 |
Thiol-PEG5-acid,CAS号:1449390-67-3 |
141 |
h |
2024-12-24 |
| 82635 |
DSPE-PEG45-NH-Mal 磷脂-四十五聚乙二醇-NH-马来酰亚胺 |
246 |
zyl |
2024-12-24 |
| 82636 |
Fmoc-Phe-Lys(Trt)-PAB,抗体- 药物偶联物 |
130 |
hyy |
2024-12-24 |
| 82637 |
HO-PEG8-CH2COOtBu,羟基八聚乙二醇叔丁酯 |
142 |
wyh |
2024-12-24 |
| 82638 |
Mal-NH-PEG45-CH2CH2COOH的介绍 |
218 |
zyl |
2024-12-24 |
| 82639 |
meso-四苯基四苯并卟啉(TPTBP) |
217 |
WYQ |
2024-12-24 |
| 82640 |
Amino-PEG2-CH2CO2-t-butyl ester,氨基-聚乙二醇2-乙酸叔丁酯 |
207 |
wyh |
2024-12-24 |
| 82641 |
HO-PEG45-CH2CH2COOtBu的介绍 |
188 |
zyl |
2024-12-24 |
| 82642 |
蓝萼甲素脂质体,Glaucocalyxin A Liposome |
180 |
axc |
2024-12-24 |
| 82643 |
Phe-Lys(Trt)-PAB,1116085-99-4,ADC试剂 |
189 |
hyy |
2024-12-24 |
| 82644 |
榄香烯脂质体,Elemene Liposome |
293 |
axc |
2024-12-24 |
| 82645 |
mPEG45-OH 甲氧基四十五聚乙二醇-羟基 |
206 |
zyl |
2024-12-24 |
| 82646 |
Amino-PEG8-t-butyl ester,氨基-聚乙二醇8-乙酸叔丁酯 |
164 |
wyh |
2024-12-24 |
| 82647 |
盐酸柔红霉素脂质体,Hydrochloric Daunorubicin Liposome |
335 |
axc |
2024-12-24 |
| 82648 |
整合素DOTA-E-[cyclo(RGDfK(Acp))]2 |
271 |
zyl |
2024-12-24 |
| 82649 |
Biotin-SS-Py,N-[2-(2-吡啶二硫代)乙基]生物素酰胺 |
206 |
wyh |
2024-12-24 |
| 82650 |
4-Ketobenzotriazine-CH2-S-(CH2)2-COOH,CAS号:170033-08-6 |
253 |
h |
2024-12-24 |
| 82651 |
七肽DOTA-VLASSAR,CAS号:1262403-90-6 |
162 |
zyl |
2024-12-24 |
| 82652 |
多西他赛脂质体,Duoxitasai Liposome |
410 |
axc |
2024-12-24 |
| 82653 |
t-Boc-N-Amido-PEG5-CH2CO2-NHS ester的性质与功能,2743668-40-6 |
190 |
wyh |
2024-12-24 |
| 82654 |
4-Ketobenzotriazine-CH2-S-(CH2)5-COOH,CAS号:221334-33-4 |
236 |
h |
2024-12-24 |
| 82655 |
Fmoc-PEG3-C2-NHS ester,CAS号:1352827-47-4 |
137 |
h |
2024-12-24 |
| 82656 |
DOTA-TATE,CAS:177943-89-4, DOTA-3-酪氨酰基-奥曲肽 |
211 |
zyl |
2024-12-24 |
| 82657 |
Stearic acid-PEG-CH2CO2H, MW 2000 |
162 |
h |
2024-12-24 |
| 82658 |
FmocNH-PEG2-CH2CO2-NHS ester的结构特点,1194666-63-1 |
288 |
wyh |
2024-12-24 |
| 82659 |
Thalidomide-NH-CH2-COOH,CAS号:927670-97-1 |
175 |
h |
2024-12-24 |
| 82660 |
盐酸氨溴索脂质体,Ambroxol Hydrochloride Liposome |
266 |
axc |
2024-12-24 |
| 82661 |
Stearic acid-PEG-CH2CO2H (MW 3400) |
153 |
h |
2024-12-24 |
| 82662 |
CEP1347-VHL-02 |
209 |
h |
2024-12-24 |
| 82663 |
DOTA-GA(tBu)4 cas306776-79-4 大环配体化合物 |
382 |
zyl |
2024-12-24 |
| 82664 |
Z-NH-(CH2)8-NH2·HCl ; N1-叔苄氧羰基-1,8-二氨基辛烷盐酸盐 |
188 |
wyh |
2024-12-24 |
| 82665 |
Stearic acid-PEG-CH2CO2H (MW 5000) |
236 |
h |
2024-12-24 |